US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

Dutasteride and Tamsulosin HCl Capsules

Reason Failed dissolution specifications; all lots within expiry are being recalled due to out of specification dissolution results.

Teva Pharmaceuticals USA NDC 0591-3771-30 D-0069-2018
Class II · Moderate risk Terminated

Paroxetine Tablets

Reason Presence of Foreign Tablets/Capsules.

Amerisource Health Services NDC 68084-046-01 D-0091-2018
Class II · Moderate risk Terminated

Succinylcholine 20 MG/ML INJ

Reason Labeling: Incorrect or Missing Lot and/or Exp Date; incorrect expiration date on the labeling of the outer poly bag

Ace Surgical Supply Co., Inc. D-0071-2018
Class II · Moderate risk Terminated

Zoloft

Reason SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent

Pfizer Inc. NDC 0049-4960-30 D-0151-2018
Class III · Low risk Terminated

Lumigan

Reason Failed Impurities/Degradation Specifications.

Allergan Sales, LLC NDC 0023-3205-03 D-0078-2018
Class III · Low risk Terminated

Combigan

Reason Failed Impurities/Degradation Specifications.

Allergan Sales, LLC NDC 0023-9211-03 D-0077-2018
Class II · Moderate risk Terminated

ROCuronium Bromide 10 mg per mL

Reason Lack Of Assurance Of Sterility.

SCA Pharmaceuticals, LLC NDC 70004-850-09 D-0068-2018
Class II · Moderate risk Terminated

fentaNYL as citrate 2 mcg / mL

Reason Lack Of Assurance Of Sterility.

SCA Pharmaceuticals, LLC NDC 70004-0264-64 D-0063-2018
Class II · Moderate risk Terminated

SUCcinylcholine 20 mg per mL

Reason Lack Of Assurance Of Sterility.

SCA Pharmaceuticals, LLC NDC 70004-0910-29 D-0059-2018
Class III · Low risk Terminated

Methylphenidate Hydrochloride Tablets USP

Reason Failed Dissolution Specifications: Low out of specification results for dissolution.

Teva Pharmaceuticals USA NDC 0591-5884-01 D-0052-2018
Class III · Low risk Terminated

Clofarabine injection

Reason Labeling: Incorrect or Missing Package Insert: authorized generic product was packaged with the incorrect insert for the brand name product Clolar (clofarabine) injection.

Sanofi-Aventis U.S. LLC NDC 0955-1746-01 D-0056-2018
Class II · Moderate risk Terminated

Levetiracetam Oral Solution

Reason Presence of foreign substance (screw)

Hetero Labs, Ltd. - Unit III NDC 31722-574-47 D-0099-2018
Class III · Low risk Terminated

Clolar

Reason Labeling: Incorrect or Missing Package Insert.

Genzyme Corporation NDC 0024-5860-01 D-0075-2018